- 全部删除
- 您的购物车当前为空
HSD17B13-IN-64 (Compound 143) 作为一种羟基类固醇 17β-脱氢酶 13 (HSD17B13) 抑制剂,显示出对雌二醇的高效抑制作用,其IC50值 ≤ 0.1 μM。此化合物主要应用于研究肝病、代谢性疾病或心血管疾病,包括NAFLD、NASH及药物性肝损伤 (DILI)。
HSD17B13-IN-64 (Compound 143) 作为一种羟基类固醇 17β-脱氢酶 13 (HSD17B13) 抑制剂,显示出对雌二醇的高效抑制作用,其IC50值 ≤ 0.1 μM。此化合物主要应用于研究肝病、代谢性疾病或心血管疾病,包括NAFLD、NASH及药物性肝损伤 (DILI)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 6-8周 | |
50 mg | ¥ 13,800 | 6-8周 | |
100 mg | ¥ 17,500 | 6-8周 |
HSD17B13-IN-64 相关产品
产品描述 | HSD17B13-IN-64 (Compound 143), an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibits a potent IC50 value of ≤ 0.1 μM against estradiol. This compound has applications in the study of various diseases, including liver conditions like NAFLD and NASH, metabolic and cardiovascular disorders, as well as drug-induced liver injury (DILI) [1]. |
分子量 | 475.71 |
分子式 | C21H13Cl3N4O3 |
CAS No. | 2770247-34-0 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容